Just diagnosed with Myeloid neoplasm associated with FGFR1 rearrangement?
You are not alone. Here is where to start: learn the basics, find a specialist or center that sees Myeloid neoplasm associated with FGFR1 rearrangement, look for clinical trials, and connect with others living with it — all in one place.
Open the full interactive Myeloid neoplasm associated with FGFR1 rearrangement hub →Overview
Myeloid neoplasm associated with FGFR1 rearrangement is a rare condition. Also known as 8p11 myeloproliferative syndrome, Stem cell leukemia/lymphoma. Tomeko brings together the specialists, research, clinical trials, treatments and community for Myeloid neoplasm associated with FGFR1 rearrangement so you can go from overwhelmed to oriented. For authoritative medical detail, see the reference sources below.
Identifiers: ORPHA:168953 · OMIM 613523 · ICD-10 C92.7 · GARD 0017043
Find care for Myeloid neoplasm associated with FGFR1 rearrangement
Authoritative references for Myeloid neoplasm associated with FGFR1 rearrangement
Research & market landscape for Myeloid neoplasm associated with FGFR1 rearrangement
Following Myeloid neoplasm associated with FGFR1 rearrangement for research or industry? Tomeko brings together the recruiting trials, the latest literature, patient organizations, and the specialist and care-center footprint for Myeloid neoplasm associated with FGFR1 rearrangement — the real-world landscape behind the condition, in one place.
- Latest Myeloid neoplasm associated with FGFR1 rearrangement research on PubMed ↗
- Recruiting Myeloid neoplasm associated with FGFR1 rearrangement trials on ClinicalTrials.gov ↗
- Explore the Myeloid neoplasm associated with FGFR1 rearrangement research & specialist footprint on Tomeko
Researchers, patient organizations & industry: Tomeko provides de-identified, no-PHI demand and engagement signal, trial awareness, and a labeled, editorially-firewalled presence for Myeloid neoplasm associated with FGFR1 rearrangement and every rare condition. See how Tomeko works with industry →
Common questions
What is Myeloid neoplasm associated with FGFR1 rearrangement?
Myeloid neoplasm associated with FGFR1 rearrangement is a rare condition. Also known as 8p11 myeloproliferative syndrome, Stem cell leukemia/lymphoma. For an authoritative medical description see the reference sources on this page; Tomeko brings the specialists, clinical trials, patient organizations and community for Myeloid neoplasm associated with FGFR1 rearrangement together in one place.
What are the symptoms of Myeloid neoplasm associated with FGFR1 rearrangement?
Symptoms of Myeloid neoplasm associated with FGFR1 rearrangement vary from person to person. For a reviewed, plain-language overview see the authoritative references below (NIH GARD, Orphanet), and discuss your own symptoms with a clinician who treats Myeloid neoplasm associated with FGFR1 rearrangement.
How is Myeloid neoplasm associated with FGFR1 rearrangement treated?
Treatment for Myeloid neoplasm associated with FGFR1 rearrangement depends on the individual and is managed by specialists. Use Tomeko to find clinicians and Centers of Excellence who see Myeloid neoplasm associated with FGFR1 rearrangement, and review current options with them.
What causes Myeloid neoplasm associated with FGFR1 rearrangement — is it genetic?
The cause and inheritance of Myeloid neoplasm associated with FGFR1 rearrangement are described in the authoritative references linked on this page. A genetics or specialist clinician who treats Myeloid neoplasm associated with FGFR1 rearrangement can explain what it means for you and your family.
I was just diagnosed with Myeloid neoplasm associated with FGFR1 rearrangement — what should I do first?
Start by learning the basics from an authoritative source, find a specialist or center that sees Myeloid neoplasm associated with FGFR1 rearrangement, and connect with a patient organization. Tomeko brings these together on one hub.
Where can I find a specialist for Myeloid neoplasm associated with FGFR1 rearrangement?
Use Tomeko's specialist and Centers-of-Excellence directories to find clinicians who treat Myeloid neoplasm associated with FGFR1 rearrangement, filtered to your area.
Are there clinical trials for Myeloid neoplasm associated with FGFR1 rearrangement?
Tomeko shows live, recruiting studies for Myeloid neoplasm associated with FGFR1 rearrangement from ClinicalTrials.gov on the hub.
Related conditions
Other conditions on Tomeko you may be looking for: